PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
The Cambridge/London Corridor: Its Strength and Impact on the UK – Harriet Fear, One Nucleus
Editorial Archive

The Cambridge/London Corridor: Its Strength and Impact on the UK – Harriet Fear, One Nucleus

The UK has one of the strongest and most productive life sciences sectors in the world, generating turnover of over £50 billion. There are nearly 5000 companies in t...
Continue Reading →
Editorial Archive

The Evolution of the Life Sciences Sector and the Role of Biotech Incubators –

The life science sector is growing in significance to the world economy, and in particular for London and the UK. A biotech incubator with a 15-year history, the Lon...
Continue Reading →
Changing Healthcare Landscape and its Impact on the Pharmaceutical Industry – Sunil Shewale, Sameer Parekh, Serum Institute
Editorial Archive

Changing Healthcare Landscape and its Impact on the Pharmaceutical Industry – Sunil Shewale, Sameer Parekh, Serum Institute

The pharmaceutical industry is a success story providing employment and ensuring that essential drugs at affordable prices are available to the therapeutic naïve pop...
Continue Reading →
Editorial Archive

Prioritising Health Economics Responsibilities to Impact Payer Pricing and Formulary Decisions – Victoria Cavicchi, Cutting Edge Information

Throughout a product’s lifecycle, health economics and outcomes research (HEOR) teams take on a number of activities to support a company’s broader market access eff...
Continue Reading →
US Healthcare Prepares for ICD-10 Transition -Jeffrey Goldstein, Allscript
Editorial Archive

US Healthcare Prepares for ICD-10 Transition -Jeffrey Goldstein, Allscript

This year US healthcare organisations are preparing to move from 13,000 ICD-9 codes to 68,000 ICD-10 codes (and this does not include procedures). It is a monumental...
Continue Reading →
The Future of Commercial Innovation in a Global Multichannel Marketplace – Jan van den Burg, Veeva
Editorial Archive

The Future of Commercial Innovation in a Global Multichannel Marketplace – Jan van den Burg, Veeva

In an increasingly global marketplace, the challenge facing life sciences companies to harmonise their operations for maximum efficiency is greater than ever. This g...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026